MENU
VTRS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Viatris (VTRS) Ownership - Who owns Viatris?

Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs... Show more

Profile

Industry
N/A
Address
1000 Mylan Boulevard
Phone
+1 724 514-1800
Employees
30000
Web
https://www.viatris.com

Details

Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
22.87B
P/E Ratio
-53.81
Total Cash
1.51B
Projected Growth
3.32
Total Debt
13.63B
Revenue
14.74B
Risk (Beta)
0.99
Dividend Yield
0.02
Total Cash/Share
1.32
Total Debt/Equity
N/A
Revenue/Share
12.64 USD as % of share price
Who owns Viatris? VTRS symbol Ownership - Tickeron.com